All In MedTech

Device Trial Radar · NCT06040827

A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension

Last checked: Nov 20, 2026Latest source record: Feb 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

626

Planned (sponsor's estimate)

Start

Sep 12, 2023

Primary completion

Jun 2028

Study completion Dec 2028

Sponsor

Lead sponsor
Canary MedicalNot on our public-company list
Sponsor type
Industry
Collaborators
NAMSA
First posted
Sep 18, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

The objectives of this prospective observational cohort study are to evaluate the safety, reliability, reproducibility, and accuracy of the Canary canturioTM te post-TKA.

Conditions

  • Knee Osteoarthritis

Interventions

  • Total Knee ArthroplastyDevice

    The nature, severity, and frequency of safety risks (Adverse Events) in subjects with the Canary canturioTM te will be compared to those subjects with the legally marketed Zimmer Persona® Personalized Knee System with 14 mm x +30 mm stem extension within 5 years post-TKA.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety - Adverse EventsTime frame: 5 years post TKA

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Ozark Orthopaedics

    Fayetteville, Arkansas · Recruiting

  • Foundation For Orthopaedic Research and Education

    Tampa, Florida · Recruiting

  • Northside Hospital

    Atlanta, Georgia · Recruiting

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.